期刊文献+

正元胶囊防治肺腺癌A549移植瘤裸鼠化疗相关性疲劳的疗效及机制研究 被引量:5

Therapeutic Effects of Zhengyuan Capsules for Chemotherapy-Related Fatigue in Nude Mice with Lung Adenocarcinoma A549 Xenografts and Its Mechanism
下载PDF
导出
摘要 【目的】探讨正元胶囊防治化疗相关疲劳的疗效及作用机制。【方法】将80只BALB/c-nu裸鼠分为正常组、模型组、顺铂组、联合治疗组,每组20只。复制肺腺癌A549移植瘤裸鼠模型。成功造模后,顺铂组给予顺铂5 mg/kg腹腔注射,每3 d1次;联合治疗组给予裸鼠顺铂5 mg/kg腹腔注射,每3 d 1次,及正元胶囊1.8 g/kg灌胃,每天1次;正常组和模型组给予相应体积的生理盐水灌胃。连续21 d。通过力竭游泳实验、悬尾实验、旷场实验评估疲劳程度。检测各组裸鼠的肝糖原含量、外周血象与外周血肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)、粒细胞集落刺激因子(G-CSF)、促红细胞生成素(EPO)、白细胞介素3(IL-3)等细胞因子水平以及骨髓有核细胞计数,观察骨髓细胞涂片。【结果】顺铂组化疗后出现动物行为学的恶化。与顺铂组比较,联合治疗组裸鼠的力竭游泳时间延长,悬尾不动时间缩短,旷场实验总运动距离延长、平均运动速度提高,肝糖原含量增加,外周血白细胞(WBC)、血红蛋白(HGB)和骨髓有核细胞增加,TNF-α和IL-6水平降低,G-CSF、EPO及IL-3水平升高(P<0.05或P<0.01或P<0.001)。【结论】正元胶囊可有效改善肺腺癌A549移植瘤裸鼠化疗相关疲劳症状,其机制可能与增加肝糖原储备,减轻化疗后裸鼠的骨髓抑制,降低血清中炎症相关细胞因子TNF-α和IL-6的含量,同时提高与骨髓造血功能相关的集落刺激生长因子G-CSF、EPO及IL-3水平有关。 Objective To explore the therapeutic effects of Zhengyuan Capsules(a registered proprietary Chinese medicine)for chemotherapy-related fatigue(CRF)and its mechanism.Methods Eighty BALB/c-nu nude mice were randomly divided into normal group,model group,cisplatin group and combination treatment group,20 nude mice in each group.The nude mouse model with lung adenocarcinoma A549 xenografts was established.After successful modeling,the cisplatin group was given intraperitoneal injection of 5 mg/kg of cisplatin every 3 days,the combination treatment group was given an intraperitoneal injection of 5 mg/kg of cisplatin every 3 days and intragastric administration of 1.8 g/kg of Zhengyuan Capsules each day.The normal group and model group were given intragastric administration of the same volume of normal saline.The treatment lasted 21 days.The forcedswimming test,tail suspension test and open field test were carried out for evaluating fatigue degree,meanwhile,the hepatic glycogen content,peripheral hemogram,the levels of cell factors including tumor necrosis factorα(TNF-α),interleukin 6(IL-6),granulocyte colony-stimulating factor(G-CSF),erythropoietin(EPO),interleukin 3(IL-3)and bone marrow nucleated cell count were detected and the bone marrow cell smear was observed in various groups.Results The behavior disorder results in CRF mice tended to worsen in the cisplatin group.Compared with the cisplatin group,the longer exhaustive swimming time,shorter immobility time during tail suspension test,longer total movement distance and higher average moving speed during open field test,increased hepatic glycogen level,higher white blood cell count,henroglobin(HGB)and bone marrow nucleated cell counts,reduced TNF-αand IL-6 levels,increased G-CSF,EPO and IL-3 levels were exhibited in the combination treatment group(P<0.05 or P<0.01 or P<0.001).Conclusion Zhengyuan Capsules have therapeutic effects on alleviating the cisplatin-induced CRF in the mice,and its mechanism is related with enhancing the post-chemotherapy hepatic glycogen content,reducing bone marrow suppression,and decreasing the serum levels of inflammation-related factors TNF-αand IL-6,and increasing the serum levels of marrow hemopoietic function-related colony-stimulating factors G-CSF,EPO and IL-3.
作者 关洁珊 罗智杰 肖志伟 林丽珠 GUAN Jie-Shan;LUO Zhi-Jie;XIAO Zhi-Wei;LIN Li-Zhu(Cancer Center,the First Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510405 Guangdong,China)
出处 《广州中医药大学学报》 CAS 2020年第5期929-937,共9页 Journal of Guangzhou University of Traditional Chinese Medicine
基金 广东省科技计划项目(编号:2016B090918059) 广州市科技计划项目(编号:201707010299) 广东省医学科研基金项目(编号:B2019148)。
关键词 正元胶囊 化疗相关性疲劳 肺癌 骨髓抑制 细胞因子 疾病模型 动物 裸鼠 Zhengyuan Capsules chemotherapy-related fatigue lung cancer bone marrow suppression cytokines disease models,animal nude mice
  • 相关文献

参考文献1

二级参考文献52

  • 1Siegel R, MaJ, Zou Z, et al. Cancer statistics 2014. CA Cancer J Clin, 2014, 64(1): 9-29.
  • 2Roselli M, Mariotti S, Ferroni P, et al. Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: Long-term survival in a randomized study. IntJ Cancer, 2006, 119(4): 955-960.
  • 3DouiUard JY, Rosell R, De LM, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association[ANITA]): a randomised controlled trial. Lancet Oncol, 2006, 7(9): 719-727.
  • 4Asamura H, Goya T, Koshiishi Y, et al. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J ihorac Oncol, 2008, 3(1): 46-52.
  • 5Li Z, Yu Y, Luo Q., etal. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.J lhorac Oncol, 2009, 4(6): 702-709.
  • 6Strauss GM, Herndon JE 2nd, Maddaus MA, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small- cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.J Clin Oncol, 2008, 26(31): 5043-5051.
  • 7Malhotra J, Mhango G, Gomez JE, et al. Adjuvant chemotherapy for elderly patients with stage I non-small cell lung cancer (NSCLC) with tumors > 4 cm: A SEER-Medicare analysis. J Clin Oncol, 2014, 32(15s): e18508.
  • 8Peters S, Weder W, Dafni U, et al. Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters. J Thorac Oncol, 2014, 9(11): 1675-1684.
  • 9Ou SH, Zell JA, Ziogas A, et al. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer, 2007, 110(7): 1532-1541.
  • 10Kudo Y, Saji H, Shimada Y, et al. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes? EurJ Cardiothorac Surg, 2012, 42(3): 414-419.

共引文献4

同被引文献56

引证文献5

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部